B
Vertex Pharmaceuticals Incorporated VRTX
$387.18 -$1.76-0.45% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 59.82% -29.21% -12.67% 129.09% -426.81%
Total Depreciation and Amortization 6.82% 127.23% -59.96% -1.48% 0.93%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -69.21% 111.93% 62.97% 314.96% 13.22%
Change in Net Operating Assets 50.69% 52.07% -455.68% 165.24% -286.70%
Cash from Operations 31.04% 40.08% -57.32% 136.49% -387.28%
Capital Expenditure -257.99% 56.05% -36.78% 1.88% -0.88%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -2,143.71% 97.93% -160.19% 28.98% 80.91%
Cash from Investing -768.28% 93.21% -136.18% 24.95% 78.30%
Total Debt Issued -- -- -- -- --
Total Debt Repaid 0.00% 0.00% 75.93% 60.58% -3.79%
Issuance of Common Stock 194.01% -51.31% 308.33% -84.73% 225.44%
Repurchase of Common Stock 42.91% -63.83% -8.64% 2.35% -9.90%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -12.50% -11.11% 0.00% 0.00% -74.29%
Cash from Financing 48.68% -73.88% -0.98% -8.06% -0.31%
Foreign Exchange rate Adjustments 87.54% 164.48% -307.46% 1,012.00% 83.97%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 162.01% 116.75% -202.86% 114.35% -280.61%